News
Returning to the United States for its third year, Environmental Finance's annual Sustainability Data America conference provides attendees with solutions-focused, practical insights on how to manage ...
It seems Eisai and Biogen have another hurdle to jump over in their bid to get EU approval for their Alzheimer's disease therapy Leqembi. In the latest development, the European Commission has ...
People with a form of severe epilepsy will now be able to get NHS access to a new drug from UCB, Fintepla, that could significantly reduce their seizures. The NHS will fund Fintepla (fenfluramine ...
This free, ACS Member-exclusive program for Standard and Premium Package holders allows you to arrange a one-on-one appointment with a certified ACS Career Consultant. Our diverse team of Consultants ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results